HØJELSE HESTEKLINIK ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.2% 1.5% 1.3% 1.0% 0.8%  
Credit score (0-100)  67 76 78 86 92  
Credit rating  BBB A A A AA  
Credit limit (kDKK)  0.1 21.6 73.3 319.1 637.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  5,725 6,628 7,824 6,637 7,189  
EBITDA  1,849 2,622 3,241 2,138 2,603  
EBIT  1,788 2,390 3,078 1,826 2,317  
Pre-tax profit (PTP)  1,515.0 2,109.8 2,804.2 1,673.4 2,111.0  
Net earnings  1,175.6 1,638.5 2,194.7 1,311.1 1,610.6  
Pre-tax profit without non-rec. items  1,515 2,110 2,804 1,673 2,111  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  4,778 4,869 4,940 4,628 4,343  
Shareholders equity total  1,168 2,280 3,286 3,553 4,064  
Interest-bearing liabilities  3,209 3,034 2,877 2,703 2,572  
Balance sheet total (assets)  10,737 11,987 11,118 11,007 10,094  

Net Debt  1,509 755 2,099 1,681 1,075  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,725 6,628 7,824 6,637 7,189  
Gross profit growth  28.2% 15.8% 18.0% -15.2% 8.3%  
Employees  12 10 12 12 10  
Employee growth %  0.0% -16.7% 20.0% 0.0% -16.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  10,737 11,987 11,118 11,007 10,094  
Balance sheet change%  24.5% 11.6% -7.3% -1.0% -8.3%  
Added value  1,848.7 2,622.1 3,241.0 1,988.9 2,602.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  598 -142 -92 -623 -571  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  31.2% 36.1% 39.3% 27.5% 32.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  18.7% 21.2% 26.9% 16.5% 22.0%  
ROI %  39.9% 43.8% 49.8% 27.9% 33.9%  
ROE %  167.9% 95.0% 78.9% 38.3% 42.3%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  10.9% 19.1% 31.1% 33.8% 40.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  81.6% 28.8% 64.8% 78.6% 41.3%  
Gearing %  274.8% 133.1% 87.6% 76.1% 63.3%  
Net interest  0 0 0 0 0  
Financing costs %  8.8% 9.6% 10.1% 5.6% 8.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.9 1.0 1.1 1.1 1.4  
Current Ratio  1.0 1.2 1.4 1.4 1.8  
Cash and cash equivalent  1,700.7 2,278.9 778.3 1,022.9 1,496.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  173.8 971.9 1,577.2 1,737.8 2,483.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  154 262 270 166 260  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  154 262 270 178 260  
EBIT / employee  149 239 257 152 232  
Net earnings / employee  98 164 183 109 161